A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)

Clinical trial NCT00481663 · COMPLETED

Trial details

NCT number: NCT00481663
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type II Diabetes Mellitus

Start date: 2003-08-19
Primary completion: 2004-07-21
Enrollment: 555

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.